DOES ADHERENCE TO INHALED THERAPY CHANGE FOLLOWING INITIATION OF MEPOLIZUMAB IN THE TREATMENT OF SEVERE ASTHMA?

被引：0
|
作者：
d'Ancona, G. [1 ]
Liu, B. [2 ]
Wei, L. [2 ]
Green, L. [1 ]
Fernandes, M. [1 ]
Roxas, C. [1 ]
Osman, L. [1 ]
Kavanagh, J. [1 ]
Jackson, D. J. [1 ]
Kent, B. D. [1 ]
机构：
[1] Guys Hosp, London, England
[2] UCL Sch Pharm, London, England
来源：
THORAX | 2018年 / 73卷
关键词：
D O I：
10.1136/thorax-2018-212555.87
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
S81
引用
收藏
页码：A50 / A51
页数：2
相关论文
共 50 条
  • [21] Looking back to go forward: adherence to inhaled therapy before biologic therapy in severe asthma
    Costello, Richard W.
    Cushen, Breda
    EUROPEAN RESPIRATORY JOURNAL, 2020, 55 (05)
  • [22] Mepolizumab does not alter blood basophil count in severe asthma
    Wright, Adam
    Diver, Sarah
    Mccarthy, Jamie
    Marvin, Andrew
    Soares, Marcia
    Thornton, Tracy
    Bourne, Michelle
    Craner, Michelle
    Evans, Helen
    Edwards, Sarah
    Glover, Sarah
    Carr, Liesl
    Parker, Sarah
    Siddiqui, Salman
    Cousins, Dave
    Brightling, Chris
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [23] Mepolizumab does not alter the blood basophil count in severe asthma
    Wright, Adam Kelvin Alec
    Diver, Sarah
    McCarthy, Jamie
    Marvin, Andrew
    Soares, Marcia
    Thornton, Tracy
    Bourne, Michelle
    Craner, Michelle
    Evans, Helen
    Edwards, Sarah
    Glover, Sarah
    Carr, Liesl
    Parker, Sarah
    Siddiqui, Salman
    Cousins, David
    Brightling, Chris
    ALLERGY, 2019, 74 (12) : 2488 - 2491
  • [24] Risk factors for poor adherence to inhaled corticosteroid therapy in patients with moderate to severe asthma
    Masaki, Katsunori
    Miyata, Jun
    Kamatani, Takashi
    Tanosaki, Takae
    Mochimaru, Takao
    Kabata, Hiroki
    Suzuki, Yusuke
    Asano, Koichiro
    Betsuyaku, Tomoko
    Fukunaga, Koichi
    ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, 2023, 41 (02): : 113 - 120
  • [25] Adherence With Inhaled Corticosteroids In Asthma: Does Pregnancy Lead To Improved Adherence?
    Ulrik, C. S.
    Barnes, C. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [26] CLINICAL EXPERIENCE OF THE USE OF MEPOLIZUMAB IN TREATMENT OF SEVERE ASTHMA
    Syrigos, Nick
    Tsami, Maria
    Psarros, Fotios
    Makris, Michail
    Syrigou, Ekaterini
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : AB17 - AB17
  • [27] Airway autoimmune responses in severe eosinophilic asthma following low-dose Mepolizumab therapy
    Manali Mukherjee
    Hui Fang Lim
    Sruthi Thomas
    Douglas Miller
    Melanie Kjarsgaard
    Bruce Tan
    Roma Sehmi
    Nader Khalidi
    Parameswaran Nair
    Allergy, Asthma & Clinical Immunology, 13
  • [28] Airway autoimmune responses in severe eosinophilic asthma following low-dose Mepolizumab therapy
    Mukherjee, Manali
    Lim, Hui Fang
    Thomas, Sruthi
    Miller, Douglas
    Kjarsgaard, Melanie
    Tan, Bruce
    Sehmi, Roma
    Khalidi, Nader
    Nair, Parameswaran
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2017, 13
  • [29] Adherence to inhaled corticosteroid therapy and treatment escalation in the Swedish adult asthma population
    Packham, Sylvia
    Odling, Maria
    Bossios, Apostolos
    Konradsen, Jon R.
    Stridsman, Caroline
    RESPIRATORY MEDICINE, 2024, 231
  • [30] Severe asthma outcomes over two years of therapy with mepolizumab
    Elsey, Lynn
    Pantin, Thomas
    Holmes, Leanne J.
    Tavernier, Gael
    Fowler, Stephen J.
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
12345